Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,225 | 34 | 65.8% |
| Consulting Fee | $9,406 | 4 | 12.8% |
| Travel and Lodging | $9,198 | 48 | 12.6% |
| Food and Beverage | $5,127 | 88 | 7.0% |
| Honoraria | $1,110 | 1 | 1.5% |
| Education | $221.96 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $41,241 | 79 | $0 (2021) |
| Lilly USA, LLC | $14,739 | 39 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $11,311 | 31 | $0 (2019) |
| Allergan, Inc. | $2,771 | 12 | $0 (2021) |
| ABBVIE INC. | $1,984 | 13 | $0 (2024) |
| Lundbeck LLC | $1,110 | 1 | $0 (2020) |
| Eli Lilly and Company | $86.87 | 1 | $0 (2018) |
| Biohaven Pharmaceutical Holding Company Ltd. | $31.79 | 1 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $14.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $308.74 | 4 | Lilly USA, LLC ($194.07) |
| 2022 | $31.79 | 1 | Biohaven Pharmaceutical Holding Company Ltd. ($31.79) |
| 2021 | $4,106 | 17 | AbbVie Inc. ($1,869) |
| 2020 | $5,003 | 12 | Amgen Inc. ($2,975) |
| 2019 | $14,947 | 36 | Amgen Inc. ($6,250) |
| 2018 | $41,648 | 87 | Amgen Inc. ($24,680) |
| 2017 | $7,245 | 21 | Amgen Inc. ($6,849) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $72.10 | General |
| Category: Neuroscience | ||||||
| 05/30/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: Neuroscience | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $114.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $82.97 | General |
| Category: Neuroscience | ||||||
| 11/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: PRIMARY CARE | ||||||
| 12/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Neuroscience | ||||||
| 07/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | Amgen Inc. | Aimovig (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $437.50 | General |
| Category: Neuroscience | ||||||
| 05/12/2021 | Amgen Inc. | Aimovig (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Neuroscience | ||||||
| 05/12/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Neuroscience | ||||||
| 01/08/2021 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2020 | Amgen Inc. | Aimovig (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $262.50 | General |
| Category: Neuroscience | ||||||
| 05/19/2020 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $1,110.00 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 41 | 54 | $18,930 | $5,542 |
| 2020 | 3 | 49 | 80 | $24,263 | $6,762 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $6,792 | $2,173 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 24 | $7,944 | $2,152 | 27.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 18 | $4,194 | $1,217 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 49 | $13,034 | $3,374 | 25.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 17 | 17 | $8,653 | $2,607 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $2,576 | $780.59 | 30.3% |
About Dr. Morris Maizels, MD
Dr. Morris Maizels, MD is a Family Medicine healthcare provider based in Central Point, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356499305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Morris Maizels, MD has received a total of $73,289 in payments from pharmaceutical and medical device companies, with $308.74 received in 2024. These payments were reported across 178 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,225).
As a Medicare-enrolled provider, Maizels has provided services to 90 Medicare beneficiaries, totaling 134 services with total Medicare billing of $12,305. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Central Point, OR
- Active Since 01/08/2007
- Last Updated 09/05/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356499305
Products in Payments
- Aimovig (Biological) $17,297
- AJOVY (Drug) $7,536
- UBRELVY (Drug) $4,638
- VYEPTI (Biological) $1,110
- EMGALITY (Drug) $196.45
- BOTOX (Biological) $85.23
- KISUNLA (Drug) $72.10
- TEV-48125 (Biological) $54.23
- AMYVID (Drug) $39.00
- NURTEC ODT (Drug) $31.79
- BOTOX THERAPEUTIC (Biological) $17.84
- QULIPTA (Drug) $14.50
- ONZETRA Xsail (Drug) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Central Point
Dr. Samuel Hirtle, D.o, D.O
Family Medicine — Payments: $66.50
Kristopher Azevedo, Md, MD
Family Medicine — Payments: $44.64
Nathan Reed, Do, DO
Family Medicine — Payments: $21.80
Brandan Hull, Md, MD
Family Medicine
Neil Olsen, Md, MD
Family Medicine
Mr. Alan Mersch, D.o, D.O
Family Medicine